Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 251 entries
View as:

A Clinical Study That Will Assess the Effect of SEP-363856 or Prior Antipsychotic (PA) Standard of Care on Body-weight Associated Parameters in Subjects With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT05542264 Org: User:
Start: 11/15/22 End: 02/12/24 Due: 02/12/25

Study of Alternate Formulation of Aripiprazole in Agitated Patients With Schizophrenic Disorders

Phase: N/A Priority: Normal
NCT ID: NCT00036127 Org: User:
Start: 04/30/02 End: 01/31/03 Due: 01/31/04

Substudy 'B' of the Accuracy of Ingestible Event Marker (IEM) Detection by the Medical Information Device #1 (MIND1)

Phase: N/A Priority: Normal
NCT ID: NCT02404532 Org: User:
Start: 02/28/15 End: 03/31/15 Due: 03/31/16

Study of Aripiprazole in the Treatment of Patients With Acute Symptoms in Bipolar Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00036101 Org: User:
Start: 02/28/02 End: 01/31/03 Due: 01/31/04

A Trial to Explore Acceptance and Performance of Using a Digital Medicine System With Healthcare Professionals and Adults With Schizophrenia, Schizoaffective Disorder, or First Episode Psychosis on an Oral Atypical Antipsychotic

Phase: N/A Priority: Normal
NCT ID: NCT03568500 Org: User:
Start: 05/21/18 End: 09/06/19 Due: 09/06/20

A Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depressive Episode

Phase: N/A Priority: Normal
NCT ID: NCT00094432 Org: User:
Start: 06/30/04 End: 11/30/06 Due: 11/30/07

Aripiprazole in Children and Adolescents With Bipolar I Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00110461 Org: User:
Start: 03/31/05 End: 02/28/07 Due: 02/28/08

Pharmacokinetic and Safety Trial to Determine the Appropriate Dose for Pediatric Patients With Multidrug Resistant Tuberculosis

Phase: N/A Priority: Normal
NCT ID: NCT01856634 Org: User:
Start: 06/14/13 End: 12/28/17 Due: 12/28/18

Study of the Safety and Effectiveness of SAMSCA® (Tolvaptan) in Children and Adolescents With Euvolemic or Hypervolemic Hyponatremia

Phase: N/A Priority: Normal
NCT ID: NCT02012959 Org: User:
Start: 09/22/15 End: 07/24/17 Due: 07/24/18

A Trial to Assess the Effects of Prazosin or Propranolol on Blood Pressure in the Presence of Brexpiprazole/Sertraline

Phase: N/A Priority: Normal
NCT ID: NCT05189977 Org: User:
Start: 09/07/22 End: 08/03/23 Due: 08/03/24

Open-label, Single-dose Trial to Assess the Pharmacokinetics of Centanafadine Extended-release Capsules in Pediatric Participants With Attention-deficit Hyperactivity Disorder (ADHD)

Phase: N/A Priority: Normal
NCT ID: NCT04081363 Org: User:
Start: 10/07/19 End: 12/21/19 Due: 12/21/20

Study to Evaluate the Efficacy, Safety, and Tolerability of Oral OPC-34712 and Aripiprazole for Treatment of Acute Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT00905307 Org: User:
Start: 07/31/09 End: 11/30/10 Due: 11/30/11

A 12-week Extension Trial to Evaluate the Safety and Tolerability of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type

Phase: N/A Priority: Normal
NCT ID: NCT03594123 Org: User:
Start: 10/11/18 End: 09/19/22 Due: 09/19/23

Multicenter, Open-label, Safety and Tolerability Study

Phase: N/A Priority: Normal
NCT ID: NCT01649557 Org: User:
Start: 08/31/09 End: 09/30/11 Due: 09/30/12

A Clinical Study That Will Measure How Well SEP-363856 Works and How Safe it is in Adults With Generalized Anxiety Disorder

Phase: N/A Priority: Normal
NCT ID: NCT05729373 Org: User:
Start: 03/08/23 End: 02/08/26 Due: 02/08/27

A Phase IV Study of the Safety and Efficacy of Aripiprazole in Combination With Lamotrigine in the Long-Term Maintenance Treatment of Patients With Bipolar I Disorder With A Recent Manic or Mixed Episode

Phase: N/A Priority: Normal
NCT ID: NCT00277212 Org: User:
Start: 12/31/05 End: 07/31/09 Due: 07/31/10

Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Neurobehavioral Disinhibition Including Aggression, Agitation, and Irritability in Participants With Traumatic Brain Injury

Phase: N/A Priority: Normal
NCT ID: NCT03095066 Org: User:
Start: 05/30/17 End: 08/31/22 Due: 08/31/23

Study of Aripiprazole in Patients With Bipolar I Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00257972 Org: User:
Start: 10/31/04 End: 12/31/07 Due: 12/31/08

Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)

Phase: N/A Priority: Normal
NCT ID: NCT01111539 Org: User:
Start: 07/13/10 End: 09/20/11 Due: 09/20/12

A Clinical Trial to Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT04072354 Org: User:
Start: 09/11/19 End: 09/12/23 Due: 09/12/24

Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder

Phase: N/A Priority: Normal
NCT ID: NCT01727713 Org: User:
Start: 01/31/13 End: 09/30/14 Due: 09/30/15

Brexpiprazole as Combination Therapy With Sertraline in the Treatment of Adults With Post-traumatic Stress Disorder

Phase: N/A Priority: Normal
NCT ID: NCT04174170 Org: User:
Start: 10/30/19 End: 08/15/23 Due: 08/15/24

A Phase 1 Trial to Evaluate the Safety, Tolerability, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of VIS171 in Participants With Autoimmune Disease(s)

Phase: N/A Priority: Normal
NCT ID: NCT06799520 Org: User:
Start: 03/17/25 End: 03/31/27 Due: 03/31/28

Positron Emission Tomagraphy (PET) Study Following a Single Oral Dose of OPC-34712

Phase: N/A Priority: Normal
NCT ID: NCT00805454 Org: User:
Start: 12/31/08 End: 07/31/09 Due: 07/31/10

Efficacy and Safety of Tolvaptan in Subjects With Chronic Kidney Disease Between Late Stage 2 to Early Stage 4 Due to Autosomal Dominant Polycystic Kidney Disease

Phase: N/A Priority: Normal
NCT ID: NCT02160145 Org: User:
Start: 05/31/14 End: 04/18/17 Due: 04/18/18